Current updates in the medical management of obesity
Obesity is a chronic medical condition that is expected to become an indirect but leading
cause of mortality and morbidity. Obesity results in type 2 diabetes mellitus, insulin …
cause of mortality and morbidity. Obesity results in type 2 diabetes mellitus, insulin …
New medications for obesity management: changing the landscape of obesity treatment
N Boulghassoul-Pietrzykowska… - Current Opinion in …, 2013 - journals.lww.com
Treating obesity is crucial as it will ultimately result in the prevention of many related chronic
diseases and will decrease morbidity and mortality. Weight loss medications are a valuable …
diseases and will decrease morbidity and mortality. Weight loss medications are a valuable …
[PDF][PDF] The challenge of obesity treatment: a review of approved drugs and new therapeutic targets
B Bonamichi, EB Parente, RB Dos Santos… - J Obes Eat …, 2018 - researchgate.net
Obesity is a metabolic dysfunction associated with a wide range of chronic illnesses that
cause significant increases in comorbidity and mortality. According to the World Health …
cause significant increases in comorbidity and mortality. According to the World Health …
Current pharmacotherapeutic concepts for the treatment of obesity in adults
E Idelevich, W Kirch… - Therapeutic Advances in …, 2009 - journals.sagepub.com
Obesity is one of the greatest public health challenges of the twenty-first century. The World
Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were …
Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were …
An update on medical therapy for obesity
R Ness‐Abramof, CM Apovian - Nutrition in clinical practice, 2003 - Wiley Online Library
Obesity is a risk factor and exacerbates many chronic conditions, particularly diabetes, but
also hypertension, hyperlipidemia, heart disease, stroke, certain cancers, arthritis, and …
also hypertension, hyperlipidemia, heart disease, stroke, certain cancers, arthritis, and …
Beyond weight loss: added benefits could guide the choice of anti-obesity medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - Current obesity …, 2023 - Springer
Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
Pharmacotherapy of obesity in complex diseases
VP Pulipati, S Pannain - Clinical obesity, 2022 - Wiley Online Library
More than 40% of adults in the United States suffer from obesity. Obesity is inextricably
linked to many chronic illnesses like type‐2 diabetes mellitus, hypertension, hyperlipidemia …
linked to many chronic illnesses like type‐2 diabetes mellitus, hypertension, hyperlipidemia …
Current options for the pharmacotherapy of obesity
I Gouni-Berthold, HK Berthold - Current Pharmaceutical Design, 2019 - ingentaconnect.com
650 millions of adults are obese worldwide-in the US alone, forty percent of the adults are
obese. Although the obesity pandemic is constantly expanding at very high costs for health …
obese. Although the obesity pandemic is constantly expanding at very high costs for health …
Medical management of obesity: an update.
JG Karam, S El-Sayegh, F Nessim, A Farag… - Minerva …, 2007 - europepmc.org
Obesity is rapidly growing global epidemic with monumental impact on health and
economics. It is associated with multiple adverse health consequences including …
economics. It is associated with multiple adverse health consequences including …
Emerging pharmacotherapy for obesity
LJ Aronne, AG Powell, CM Apovian - Expert opinion on emerging …, 2011 - Taylor & Francis
Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have
tripled over the past three decades and are predicted to rise even further. The need for safe …
tripled over the past three decades and are predicted to rise even further. The need for safe …